Trial Profile
Open-Label Vulvoscopy Photography Study of Changes in Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Administration of 6.5 Mg Vaginal Prasterone in Menopausal Women With Moderate to Severe Dyspareunia
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2018
Price :
$35
*
At a glance
- Drugs Prasterone (Primary)
- Indications Dyspareunia
- Focus Therapeutic Use
- 29 Aug 2018 Status changed from not yet recruiting to recruiting.
- 03 Jul 2018 New trial record